Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2019 / Article

Research Article | Open Access

Volume 2019 |Article ID 1568720 | https://doi.org/10.1155/2019/1568720

Ikram Khémiri, Lotfi Bitri, "Effectiveness of Opuntia ficus indica L. inermis Seed Oil in the Protection and the Healing of Experimentally Induced Gastric Mucosa Ulcer", Oxidative Medicine and Cellular Longevity, vol. 2019, Article ID 1568720, 17 pages, 2019. https://doi.org/10.1155/2019/1568720

Effectiveness of Opuntia ficus indica L. inermis Seed Oil in the Protection and the Healing of Experimentally Induced Gastric Mucosa Ulcer

Academic Editor: Demetrios Kouretas
Received08 Jul 2019
Accepted09 Sep 2019
Published15 Nov 2019

Abstract

Gastric ulcer is a painful lesion of the gastric mucosa which can be disabling, or even more very serious in the case of a perforation of the stomach and internal hemorrhage. Traditional pharmacopeias have shown the efficacy of various plant extracts in the treatment of this pathology. Some extracts from Opuntia ficus indica (OFI) have been proven to have medicinal therapeutic benefits. The aim of this study was to investigate the preventive and curative effects of OFI seed oil extracted by cold pressing on an ethanol-induced gastric ulcer model in rats. Gastroprotective activities of the oil were assessed as pretreatments prior to ethanol gavage of Wistar rats compared to reference drugs. Two oil dose effects were tested. Ulcer and gastric parameters were measured (ulcerated areas (mm2), % of ulcer inhibition, gastric juice volume and pH, and mucus weight). Macroscopical and microscopical assessments of the stomachs as well as gastric biopsy histological studies were carried out. OFI oil exhibited a high efficiency in the protection of the cytoarchitecture and function of the gastric mucosa against the severe damages provoked by ethanol intake. Ulcerated areas were very significantly reduced and the % of ulcer inhibition was the highest under OFI oil pretreatment. Mucus production was stimulated, gastric juice volume was reduced, and its pH was increased. Histopathological examination of H&E-stained biopsies collected from gastric mucosae from the different experimental groups confirmed the gastroprotective efficacy of OFI oil against ethanol-induced symptoms such as inflammation and damages like bleeding, erosions, lesions, necrosis, and ulcers. Furthermore, OFI oil treatment speeded-up the reduction of the surface of ethanol-induced ulcerated areas in a dose-dependent manner, leading to a time gain in the healing process. The healing rate reached 91% on day 2 and 99% on day 3, and a complete heal was attained at the fourth day under OFI oil treatment, while ulcer areas were still partially unhealed in all the other groups. The therapeutic effects of OFI oil against gastric ulcer could be mediated by its varied bioactive compounds that we have demonstrated in the analytical study. They could act synergistically or in a delayed manner to optimize the healing process through protective antioxidant properties, as well as an antagonism against histamine H2-receptors, a stimulation of the signaling pathways necessary for mucus and bicarbonate production, and reduction of inflammatory processes in the gastric mucosa. Additionally, OFI oil fatty acids (especially unsaturated) and triacylglycerols contribute to the reconstruction and the repair of the cell membrane lipid bilayer during the gastric ulcer healing process.

1. Introduction

Gastric ulcer is considered one of the most common human gastroduodenal disorders in the world. It is a disease characterized by a painful lesional excoriation, extending at least to the muscular mucosa of the gastric and/or duodenal wall, and more rarely of the lower portion of the esophagus close to the ostium cardiacum. It can be disabling due to epigastralgias, even serious if the stomach is perforated, leading to internal bleeding and so to death if not urgently treated [1, 2]. The main etiologies of peptic ulcer are the imbalance between the secretion of gastric hydrochloric acid and pepsin, and/or the reduction of the cytoprotective capacities of the gastroduodenal mucosal barrier by the secretion of mucus, bicarbonate, prostaglandins, and cellular antioxidants [3, 4]. In recent years, it was well admitted that the occurrence of a peptic ulcer is mainly due to infection with Helicobacter pylori (HP) [5, 6]. On a global scale, more than half of the world’s population is infested by this bacteria and this rate reaches about 80% in developing countries [79]. The correlation between such infection and digestive diseases such as gastric and/or duodenal ulcers, chronic erosive gastritis, stomach and/or duodenal cancer, and malt lymphomas has been reported [10, 11]. Indeed, infection of the gastric mucosa by HP evolves in several cases into active chronic gastritis which causes in about 50% of the cases an atrophy of the gastric wall, an intestinal metaplasia which is complicated in about 20% of the cases in dysplasia and then in gastric cancer [12]. Other factors are well known to be involved in gastric ulcer induction such as medication by nonsteroidal anti-inflammatory drugs (NSAIDs) such as acetylsalicylic acid (ASA), essentially chronic emotional stress, overconsumption of alcohol and related drinks, and tobacco smoking [1315]. For instance, the risk of developing upper and lower gastroduodenal bleeding is high in patients treated with ASA, in the prevention or in the treatment of ischemic cardiovascular diseases [16, 17]. Although the treatment of HP infections has improved significantly in recent years due to the development of the antibiotic pharmaceutical industry, the prevalence of peptic ulcer morbidity has not decreased accordingly and mortality from such a pathology (2.5% to 5.8%) still remains a public health concern [18]. Conventional treatments for peptic ulcers are based on one hand on the reduction of factors that induce gastric mucosal damage, such as proton pump inhibitors (IPPs), anticholinergics, histaminic H2-receptor antagonists, and antacids, and on the other hand on the improvement of the protective mucosal layer by mucus production or by synthetic mucus mimetic drugs [6, 19, 20]. Drugs are not without risks and trigger short- and long-term side effects on human health. Some of these side effects are abdominal pains, headache, vertigo, arrhythmias, metabolic disorders (hypomagnesemias, Vit. B12 deficiencies, and hematopoietic changes), nephritis, bone damage, and some forms of cancer [21, 22]. That is why several researches focused on the discovery of alternative medicines or therapies, based on the much diversified natural potential of bioactive compounds in plants that would clearly be less aggressive than conventional drugs [20, 23]. Several plants have pharmacological relevance since they are used in traditional or ethnopharmacopeias. In this sense, various studies around the world have reported the gastroprotective and/or healing effects of plant extracts (flowers, stems, leaves, roots, cladodes, and mucilages) on peptic ulcer induced in animal models [2434].

The mucous membranes are contiguous to the skin which constitute the external protective barrier of the human body. They ensure the protection of the body’s internal cavities which are in relation to the external environment (respiratory, digestive, urinary, and reproductive systems). If the skin is protected by the squamous layer composed of dead keratinocytes, the internal mucous membranes are protected by mucus since the cells covering them are all living cells and are highly permeable, much more than the skin.

It is well admitted that the aim of healing skin injuries of full-thickness excisions, incisions, burns, erosions, and ulcers is to promptly close the wounds by full reepithelialization, in order to avoid microbial infections and to restore the elasticity and functionality of the extracellular dermal matrix, as well as the reformation of the skin appendages. The healing of gastric ulcers is also intended to restore the gastric epithelium and to reconstruct the extracellular matrix in order to close the wounds and also to restore all the glandular and other structures that constitute the gastric wall.

Some of the methods used for the assessment of the gastrodefensive effects of plant extracts or synthetic drugs are the pylorus ligation model [35, 36] and the peptic ulcer models induced by HCL, HCL/ethanol [37, 38], acetic acid [39], and NSAIDs [40]. The ethanol-induced ulcer model in rats or mice still remains one of the most used method in the investigation of the therapeutic and/or preventive activities of active compounds, especially those from plant extracts. Indeed, ethanol was reported to prompt severe damages to gastric and duodenal mucosa by causing disturbances in the environmental equilibrium of gastroduodenal cavities [4147].

Some fixed vegetable oils extracted by various processes (solvent, supercritical CO2, and cold pressure) have been proven to heal skin wounds [4852]. In a previous work, we showed the effectiveness of Opuntia ficus indica oil (OFI oil) extracted by cold pressing on the healing of full-thickness skin injury, as well as its antimicrobial effect against bacteria, yeast, and fungi [53].

The current study was devoted to the investigation of the gastroprotective as well as healing potential of OFI oil as a therapeutic against ethanol-induced peptic ulcer in rat model.

2. Methods and Materials

2.1. Sample Collection

Fruits of prickly pear Opuntia ficus indica were harvested in the months of July and August 2015 at the village of Zelfen, located in the Thala delegation, in the governorate of Kasserine in central Tunisia. The GPS coordinates are as follows: 35°2908N and 8°4509E at an altitude of 985 m. The climate is semiarid (BSh/BSk according to the Köppen climate classification). Winters are generally chilly and wetter with snowfalls, while summers are moderately hot. The fruits were washed with clear water and drained. Then, they were peeled manually and the seeds were isolated mechanically, washed with potable water and dried in the open air.

2.2. Oil Extraction

The extra virgin oil of mature prickly pears seeds was naturally extracted by first cold pressing using a mechanical machine in order to preserve the quality of its components. The oil was filtered and stored in anti-UV hermetic bottles at room temperature.

2.3. Reagents and Drugs

Absolute ethanol was purchased from VWR Chemicals, Prolabo (France); sucralfate (Ulcar, 1 g; Sanofi-Aventis, France) and ranitidine (Azantac, 75 mg; GlaxoSmithKline, France) were acquired from a local pharmacy. The drug doses were prepared immediately before administration to the rats.

2.4. Physicochemical Screening of OFI Oil Extracted by Cold Pressing

The analyses were performed at the laboratories of the National Oil Office of Tunisia (ONH).

2.4.1. Physicochemical Characteristics

The analyses were carried out according to the official methods of AOAC (American Oil Chemists’ Society, International). Saponification index was determined according to the Norm ISO 3657: 2013. Peroxide value was estimated in meq O2/kg of oil (NF T60-2201998). Refractive index was measured at 20° with an Abbe refractometer with temperature adjustment. Density was determined at 20° by gravimetry. Acid index and iodine value (g I2/100g) were calculated according to NF ISO 660-1996 and AOAC official method 940.28 (2013), respectively.

2.4.2. Free Fatty Acid Analysis

The identification and the quantification of the free fatty acids in the Opuntia ficus indica seed oil were performed using the Gas-Chromatography-Flame Ionization Detection (GC-FID) method. Briefly, fatty acids were extracted and methylated according to the method described [54] and modified [55]. Fatty Methyl Esters (FAMEs) were analyzed using a gas chromatograph (HP 4890) equipped with a flame ionization detector (FID). The separation of FAMEs was performed on a Supelco wax-coated capillary column ( i.d. and 0.25 μm film thickness). The injection was carried out with a split/splitless capillary injector (split ratio 1 : 10) and flushed with helium as carrier gas at a flow rate of 1 mL/min. Temperatures of the column, detector, and injector were, respectively, 200, 250, and 230°C. The fatty acid relative peaks were identified by comparing their retention time’s standard mixture, analyzed under the same procedure. The total area was measured and served to calculate the percentage of each area under each peak, corresponding to each fatty acid. The area under each peak was measured and the percentage expressed in regard to the total area.

The calculated oxidizability (Cox) value of the oil was calculated applying the formula based on the percentage of unsaturated C18 fatty acids, proposed by Fatemi and Hammond [56]:

2.4.3. Triacylglycerol (TAG) Analysis

The analysis of triacylglycerol (TAG) fractions in OFI oil was carried out by the official qualitative and quantitative chromatographic method of the Equivalent Carbon Number (ECN 42) [57]. 0.5 g of the oil sample was dissolved in 10 mL acetone (sample solution). A chromatograph (Shimadzu, Kyoto, Japan) equipped with a refractometer detector was employed. A Spherisorb Column (, 5 μm particle size) from Supelco (USA) permitted the separation of the TAGs. The elution was carried out with a 50 : 50 acetone/acetonitrile mixture; the flow rate was 1.5 mL/min, the column temperature was 30°C, and the injection volume was 20 μL of the sample solution. The retention times were compared to standards.

2.4.4. GC-FID Phytosterol Analysis

The OFI oil sterol identification and quantification were performed by Gas Chromatography-Flame Ionization Detection (GC-FID) [58]. Sterols separated from the rest of the OFI oil components were transformed into trimethylsilyl ethers (TMSs) and then analyzed by CPG-FID on a fused silica capillary column (30 cm long, 0.3 mm inside diameter) operated isothermally at 280°C. The injector temperature was maintained at 280°C and the FID detector at 290°C. Vector gas (pure helium) linear speed was 35 cm/s. The sterol fractions were identified based on a sterol mixture of known composition analyzed chromatographically under the same conditions as the tested OFI oil sample. Alpha-cholestanol was used as an internal standard.

2.4.5. Tocopherol Analysis

The identification and quantification of the tocopherol fractions were carried out by high-pressure liquid chromatography (HPLC) [59].The HPLC system consisted of a low-pressure quaternary pump HP-1050, a Rheodyne injection valve (20 mL loop), a thermostatic furnace, and a fluorescence detector RF-535 (Shimadzu, Kyoto, Japan). Separation was performed in a particle size 5 μm LiChrospher Si-60 (Merck, Darmstadt, Germany) column. The column and detector were firstly separated and then detected with a UV detector.

2.4.6. Total Chlorophyll and Carotenoid Content

OFI oil (1.5 g) was dissolved in 5 mL cyclohexane. Chlorophyll and carotenoid amounts were determined by the colorimetric method described in [60]. The maximum absorption was measured at 670 nm which is related to the chlorophyll fraction and at 470 nm which corresponds to the carotenoid fraction. where “613” and “2.000” correspond, respectively, to the specific extinction coefficients of pheophytin (chlorophyll “a”, which is the major component of the chlorophyll fraction) and lutein (a xanthophyll, a major component of the carotenoid fraction) (Figure 1). “” was the absorbance and “” was the thickness (1 cm) of the spectrophotometer cell. The amounts of the two pigments were expressed as mg/kg OFI oil.

2.4.7. Total Phenolic Content

Total phenolic content in OFI oil was quantified using the Folin-Ciocalteu method as described in [61]. An OFI oil-diluted solution (20 μL) was added to 100 μL of a Folin-Ciocalteu Reagent (0.2 N). The tubes were incubated at room temperature in the dark. 80 μL of sodium carbonate Na2CO3 water solution (7.5%) was added to the mixture. All measurements were performed in triplicate. Absorbance was determined after 60 min at 765 nm against a blank. Total phenolics were expressed as mg of Gallic acid equivalents per g of oil (G.A. eq/g oil).

2.4.8. Total Flavonoid Content

The determination of the flavonoid content in OFI oil was carried out as described in [62] but slightly modified. To an aliquot of 1.5 mL DMSO, dissolved oil was added to 1.5 mL of AlCl3 (2%). Absorbance was measured after 30 min incubation in the dark at 430 nm vs. a blank. Quercetin was used as standard. Total flavonoids were expressed as mg of Quercetin equivalents per g of oil (Q eq/g oil).

2.4.9. Scavenging Ability against 1,1-Diphenyl-2-picrylhydrazyl Radical (DPPH Assay)

The scavenging activity towards the DPPH radical of OFI oil was evaluated using the method described in [63]. 20 μL of OFI oil dilution was mixed with 180 μL of 0.1 mM DPPH solution. After shaking vigorously, the mixture was left to incubate for 30 min in the dark at room temperature. The absorbance was measured at 520 nm using a spectrophotometer (Thermo Fisher Scientific Multiskan GO). The wavelength of maximum absorbance of DPPH was recorded as . The absorbance of the blank control was recorded as . Ascorbic acid was used as standard. All measurements were performed in triplicate.

The percentage of inhibition (%) of the free radical DPPH was calculated as follows:

The results were expressed as Vit. C eq/g oil.

2.4.10. Determination of 2,2-Azinobis-3-ethylbenzothiazoline-6-sulfonate Free Radical (ABTS) Free Radical Scavenging Activity

An ABTS assay was carried out as described in [63]. An ABTS radical cation was produced by mixing 7 mM ABTS solution (at pH 7.4) with 2.5 mM potassium persulfate. This mixture was stored in the dark at room temperature for 16 h before use. A dilution was performed until an absorbance of at 734 nm was reached. 20 μL of the sample was added to 180 μL of fresh ABTS-diluted solution. Absorbance was measured 6 min after mixing. Ascorbic acid was used as standard reference. The capacity of free radical scavenging was estimated using the same equation mentioned above for the DPPH scavenging activity. The measurements were performed in triplicate. The results were expressed as Vit. C eq/g oil.

2.5. Experimental Study Design
2.5.1. Animals

Adult male albino Wistar rats purchased from SIPHAT (Tunis, Tunisia) weighing from 180 to 190 g were acclimated for 2 weeks in the laboratory under environmentally controlled conditions: temperature of , 12 h light/12 h dark daily artificial cycle, and air humidity. They were allowed a standard commercial pellet diet and potable water ad libitum. The animals were handled accordingly to the current guidelines of the Tunisian Society for the Care and the Use of Laboratory Animals (ATSAL), and the protocol for rat studies was approved locally by the Institutional Animal Ethics Committee for Animal Care and Use for scientific purposes.

2.5.2. Acute Toxicity of Opuntia ficus indica Seed Oil (OFI Oil)

A total of 30 adult rats were divided into three groups (). The first group served as control. The second and the third groups were, respectively, administered per os (p.o.) 3.5 mL and 7 mL of OFI oil/kg/body weight (bw). They were observed for symptoms of toxicity like ataxia, convulsion, irregular respiration, diarrhea, hind legs paralysis, or mortality during 5 days.

2.5.3. Gastroprotective Investigation Procedure

The antiulcerogenic effects of OFI oil were investigated using the ethanol-induced ulcer model in rats as described in [64]. The rats were fasted for 48 hours before experiments. Then, they were divided into 6 groups of ten animals each: (i)Group 1: negative control group, was administered by intragastric gavage (ig) 1 mL of normal saline(ii)Group 2: positive control group, was administered by ig 1 mL of normal saline and one hour later 1 mL of absolute ethanol(iii)Group 3: sucralfate group, pretreated by ig with 1 g/kg/bw of sucralfate (Ulcar, 1 g) and one hour later 1 mL of absolute ethanol(iv)Group 4: ranitidine group, pretreated by ig with 50 mg of ranitidine (Azantac, 75 mg)/kg/bw and one hour later 1 mL of absolute ethanol(v)Group 5: dose 1 oil group, pretreated by ig with 3.5 mL of OFI oil/kg/bw and one hour later 1 mL of absolute ethanol(vi)Group 6: dose 2 oil group, pretreated by ig with 7 mL of OFI oil/kg/bw and one hour later 1 mL of absolute ethanol

After one hour to ethanol exposure, the stomachs were removed from each rat, cut along the great curvature, and internally inspected. Gastric ulcerated area surface, ulcer index, percentage of inhibition of ulceration, gastric mucus weight, and volume and pH of the gastric juice were determined.

The gastric ulcerated area surface was calculated in mm2 by planimetry, tracing all the ulcerated areas on a transparent graph paper, then summing them. The ulcer index (UI) was estimated as described in [64]. UI was evaluated as the mean ulcerated areas (mm2). The percentage of inhibition was calculated using the following formula [65]:

The mucus covering the gastric mucosa of each rat was gently scraped using a clean glass slide, then weighed using a sensitive balance, and the gastric volume measured using a graduated test tube as described in [27]. Gastric juice acidity was measured using a digital pH meter. A gross assessment of the state of the stomachs was carried out by photographing the upper surface of the gastric mucosae with a Sony DSC-W270 digital camera.

2.5.4. Gastric Mucosa Ulcer Healing Effect of OFI Oil

The induction of peptic ulcer was undertaken using the absolute ethanol ig gavage described above. One hour after inducing gastric mucosa ulcer, the animals were divided into five groups of 50 each and treated as follows: (i)Group 1: positive control group, not treated(ii)Group 2: sucralfate group, treated by ig once/day with 1 g/kg/bw of sucralfate (Ulcar, 1 g)(iii)Group 3: ranitidine group, treated by ig once/day with 50 mg/kg/bw of ranitidine (Azantac, 75 mg)(iv)Group 4: dose 1 oil group, treated by ig once/day with 3.5 mL of OFI oil/kg/bw(v)Group 5: dose 2 oil group, treated by ig once/day with 7 mL of OFI oil/kg/bw

Every day 10 animals from each group were sacrificed. Their stomachs were quickly removed, opened along the great curvature, and the ulcerated areas measured as described above. Microphotographs of the scars were taken with a microscope. The remaining animals from each group were treated with their respective treatments until the next day, and so on until the end of the treatment period which was of five days till the complete healing of the mucosa ulcer of one of the groups.

2.5.5. Histopathological Examination of Gastric Mucosa

Tissue specimens taken from 3 parts of the stomachs (cardia, fundus, and antrum) from the experimental animal groups were immersed in neutral-buffered formalin solution (10%) and dehydrated through a series of alcohol-water solutions using a Shandon tissue processor (Citadel 2000). After being cleared, the tissues were embedded in paraffin wax. The sections (5 μm thick), made using a rotatory microtome, were mounted on a microscope glass slide and stained with hematoxylin-eosin solution (H&E). The tissue preparations were examined microscopically under light and photographed with a light Olympus microscope (Tokyo, Japan) equipped with a digital camera.

2.6. Statistical Analysis

Statistical data analysis was performed using SPSS statistical package (version 20.0), followed by -test. The results were presented as the . Significance of difference between the groups was accepted if .

3. Results

3.1. Physicochemical Screening of OFI Oil
3.1.1. Physicochemical Characteristics

Table 1 presents the physicochemical characteristics of OFI oil. It is a greenish-yellow-colored, noncomedogenic, dry, and slightly fruity oil. It has a density of at 20°, an acid index of , an iodine index of (g I2/100g oil), a peroxide index of (meq O2/kg oil), a saponification index of (mg KOH/g oil), and a refractive index at 20° of .


Parameters

Physical state at room temperatureLiquid
ColorGreenish yellow
OdorSlightly fruity
PropertyDry oil
TextureNoncomedogenic
Density at 20°C (mass/volume)
Density by gravimetry at 20°C
Refractive index at 20°C
Acid index
Peroxide index (meq O2/kg of oil)
Iodine index (g I2/100 g of oil)
Saponification index (mg of KOH/g oil)

3.1.2. Fatty Acid Composition

The chromatography profile of the free fatty acid composition in OFI oil extracted by cold pressing (Figure 2) showed that the main FA were linoleic acid (C18 : 2 -6), oleic acid (C18 : 1 -9), palmitic acid (C16 : 0), and stearic acid (C18 : 0) with percentages (g/100 g of total fatty acids) of , , , and , respectively. The % of unsaturated fatty acids (UFA) was of , that of polyunsaturated fatty acids (PUFA) was , and the ratios of UFA/SFA and PUFA/UFA were and , respectively. The Cox value was (Table 2).


Content (g/100 g of total fatty acids)

Fatty acids
 C14 : 0
 C16 : 0
 C16 : 1 -7
 C17 : 0
 C17 : 1 -7
 C18 : 0
 C18 : 1 -9
 C18 : 2 -6
 C 18 : 3 -3
 C20 : 0
 C22 : 0
Fatty acid groups
 SFA
 UFA
 UFA/SFA
 PUFA
 MUFA
 PUFA/UFA (%)
 Cox value

SFA: saturated fatty acids; UFA: unsaturated fatty acids; PUFA: polyunsaturated fatty acids; MUFA: monounsaturated fatty acids; UFA/SFA: unsaturated fatty acid to saturated fatty acid ratio; PUFA/UFA: polyunsaturated fatty acid to unsaturated fatty acid ratio; values given are the means of three measurements±standard error.
3.1.3. Triacylglycerol Composition

The different categories of TAGs in OFI oil analyzed on the basis of the equivalent carbon number method (ECN 42) are presented in Table 3. Data analysis confirmed that the major fatty acids in OFI seed oil was linoleic, oleic, and palmitic acids. The positional distribution of FA in TAG indicates PUFA linoleic acid C18 : 2 -6 as the dominant homogeneous specie LLL ( of total TAG), followed by OLL ( of total TAG), PLL ( of total TAG), and SLL ( of total TAG) and OOL ( of total TAG). Other TAG species were identified at lower rates.


ECN (42)TAG (g/100 g of total TAG)

ECN 42LLL
PoLL

ECN 44OLL
PLL

ECN 46OOL
PoOO
SLL

ECN 48PLP
OOO
SOL
POO

ECN 50POP
SOO
AOO

Values given are the means of three . A: arachidic acid; L: linoleic acid; O: oleic acid; P: palmitic acid; Po: palmitoleic acid; S: stearic acid.
3.1.4. Phytosterol Composition

Figure 3 depicts the chromatographic profile spectra of the sterols in OFI oil obtained by GC-FID. Phytosterol fractions identified and evaluated in OFI oil as % of total sterols are presented in Table 4. The major sterol fraction was β-sitosterol (), followed by campesterol (). Other sterols were detected at low levels such as Δ-7-avenasterol (), stigmasterol (), clerosterol (), Δ-7-stigmastenol (), and Δ-5-24-stigmastadienol ().


Sterol fractionsContent (% of total sterols)

β-Sitosterol
Campesterol
Δ-7-Avenasterol
Stigmasterol
Clerosterol
Δ-7-Stigmastenol
Δ-5.24-Stigmastadienol
Cholesterol
Brassicasterol

Values given are the means of three .
3.1.5. Vitamin E Tocopherol Composition

Vitamin E tocopherol fractions were estimated in mg/kg oil as follows: β- and γ-tocopherols (), δ-tocopherol (), and α-tocopherol (). These fractions from total tocopherols were, respectively, 92.422%, 6.246%, and 1.331%. The results are shown in Table 5.


Tocopherol fractionsContent (mg/kg oil)% total tocopherols

1.33
92.42
6.24
Total tocopherols

Values given are the means of three .
3.1.6. Total Phenolic, Flavonoid, Carotenoid, and Chlorophyll Contents

Our findings indicated that OFI oil has a total phenolic content of 26.5 Gallic acid eq/g oil, flavonoid content of 3.1 mg Quercetin eq/g oil, carotenoid content of 10.520 mg/kg oil, and total chlorophyll content of 4.57 mg/kg oil (Table 6).


CompoundsContent

Total phenolics (Gallic acid eq/g oil)
Flavonoid mg Quercetin eq/g oil
Carotenoid (mg/kg)
Total chlorophylls (mg/kg)

Values are presented as means of three .
3.1.7. Scavenging Activity against DPPH and ABTS Free Radicals

Table 7 presents the data of the scavenging activity of OFI oil against DPPH and ABTS as percentage of inhibition compared to Vitamin C. We registered, respectively, and Vit. C eq/g oil.


Free radical% inhibition (Vit. C eq/g oil)

DPPH
ABTS

3.2. Acute Toxicity of Opuntia ficus indica Seed Oil

In this study, we did not notice any toxicity symptoms or mortality in the orally treated animals neither with the dose of 3.5 mL nor with dose of 7 mL of OFI oil/kg/bw over the five days of the experimental period.

3.3. Protective Effect Study of OFI Oil against Ethanol-Induced Ulcer

Figure 4 shows the graphs of the effects of the pretreatments on ulcer and some gastric function parameters.

3.3.1. Assessment of Ulcer Parameters

Our data indicated that absolute ethanol intake (positive control) provoked a wide range of ulceration in gastric mucosa. Sucralfate pretreatment significantly reduced ulcer areas () vs. positive control. The same result was noted with ranitidine. The protective effect with ranitidine was significantly better than that of sucralfate (). Percentage of ulcer inhibition was significantly higher with OFI oil (dose 1) vs. sucralfate and ranitidine (). OFI oil dose 2 was the most efficient in reducing the ulcerated area surface by 97% ().

3.3.2. Assessment of Gastric Parameters

Absolute ethanol intake caused a significant reduction of mucus secretion (). This was prevented by the pretreatment with sucralfate (). Ranitidine and OFI oil dose 1 effects were quite similar in enhancing mucus weight and remained lower than that of sucralfate (). OFI oil dose 2 appeared to be the most efficient in enhancing mucus secretion ().

Ethanol intragastric gavage significantly enhanced () gastric juice volume compared to negative controls, ranitidine, and OFI oil dose 1 and 2 pretreatments, while sucralfate pretreatment slightly reduced this volume (). Gastric juice pH significantly decreased under alcohol intake vs. negative control (). This pH decrease was prevented preferentially by OFI oil dose 2, OFI oil dose 1, ranitidine, and sucralfate.

3.3.3. Macroscopic and Microscopic Examination of the Gastric Mucosa after Absolute Ethanol Intake

(1) Macroscopic Examination of the Gastric Mucosa. Figure 5 shows the photographs of the opened stomachs one hour after ethanol-induced peptic ulcer of the different experimental groups. Pretreatments with reference drugs sucralfate and ranitidine, as well as OFI oil (doses 1 and 2) were applied 1 hour prior to alcohol intake. We could observe the corrosive effects of absolute ethanol on gastric mucosa compared to negative control. Linear longitudinal and local black lesions indicate severe tissue necrosis, and redness in the remaining areas indicates vasodilation and inflammation. Sucralfate pretreatment alleviated ethanol-induced damages with linear longitudinal red lesions and hyperhaemia on the whole gastric mucosa surface. Ranitidine pretreatment reduced ethanol aggression on gastric mucosa. Local ulcers, erosions, and redness were registered. OFI oil pretreatment significantly alleviates alcohol-induced damages in a dose-dependent manner, thus ensuring a gastric mucosa protection.

(2) Microscopic Examination of the Upper Surface of Gastric Mucosa. The observation of the upper surface of the stomachs of the different experimental groups showed that absolute ethanol induced necrosis in some zones, active vascular congestion, and local hemorrhages. In some areas, we could note erosions and even more ulceration reaching the deepest layers of the stomach wall at the limit of stomach perforation. The intensity of these symptoms was reduced by the pretreatments. The most potent preventive pretreatment was OFI oil dose 2, followed by OFI oil dose 1, ranitidine, and sucralfate in comparison to negative and positive controls (Figure 6).

(3) Histological Investigation of Gastric Mucosal Biopsies. Histological exploration of the H&E-stained biopsies collected from the stomachs of the different experimental groups revealed the following results: (1)Treatment with absolute alcohol in the positive group caused severe vascular congestion of the lamina propria at the esophageal-cardiac junction, cellular desquamation, and a discrete surface erosion of the mucosa with moderate infiltration of neutrophils. At the fundic level, the vascular congestion was more significant as it reached the submucosal and subserosal vessels. In addition, treatment with absolute alcohol caused significant acidophilic necrosis of the crypt layer. A desquamative degeneration of the cells of the deep glands has been observed. At the antral level, a vascular congestion caused by alcohol was as severe as that observed at the fundus level. Necrosis with extensive disbonding of the crypto layer has been caused, reaching even the muscular layer in some areas, associated with the degeneration of glandular cells(2)Pretreatment with sucralfate prior to the induction of gastric ulcer by absolute ethanol reduced the symptoms observed at the three levels mentioned above. At the esophageal-cardiac junction, sucralfate provided moderate mucosal protection. Superficial desquamation and slight vascular congestion were noted. At the fundic level, we observed superficial erosion of the surface epithelium, massive desquamation of cells at the glands and crypts, and discrete inflammatory infiltration by neutrophil polymorphs of the submucosa. At the antral level, we recorded clear desquamation of the glands as well as significant vascular congestions caused by absolute ethanol and infiltration with polymorphonuclear neutrophils and macrophages(3)At the esophageal-cardial junction level, the force-feeding of the rats with absolute ethanol after pretreatment of the gastric mucosa with ranitidine caused less damage than that in the negative control and sucralfate group. Minimal cardiac desquamation, low neutrophil infiltration, and slight vascular congestion have been nevertheless observed. At the fundic level, massive cellular desquamation, some superficial exulcerations, reduced vascular congestion, and moderate polynuclear infiltration were noted. At the antral level, we noticed some neutrophil infiltrates. However, the glands were preserved.(4)Histopathological examination of the H&E-stained biopsies collected from gastric mucosae from rats pretreated with OFI oil indicated that symptoms of ethanol-induced damages were minimal. Dose 2 oil (7 mL/kg/bw) was more efficient than dose 1 oil (3.5 mL/kg/bw). At the esophageal-cardial junction, epithelial cellular desquamations and neutrophil leukocyte infiltrations in the chorion were much reduced. At the fundic and antral levels, submucosal vessel congestion was reduced. A very low epithelial cellular desquamation accompanied by some superficial erosions have been observed. Some of these observations were presented in Figure 7

3.4. Healing Effect of OFI Oil of Ethanol-Induced Gastric Ulcer

Figure 8 depicts the evolution of the ulcerated area surface in mm2 over 5 days after inducing gastric ulcer. Curve analysis indicates the reduction of the surface of ulcerated areas in gastric mucosa during the treatment period. The healing process speeds were different. We noticed a similar evolution in untreated controls, sucralfate, ranitidine, and OFI oil dose1 during the first 24 hours postulceration. On the other hand, oral treatment with OFI oil dose 2 significantly reduced the ulcerated area by almost 80%. A very slight improvement was recorded with ranitidine compared to sucralfate and control from day 2. Dose 2 of OFI oil accelerated the peptic ulcer healing at a rate of 91% on day 2 compared to OFI oil dose 1 (72%), ranitidine (55%), sucralfate (50%), and untreated control (40%). At the 3rd day postalcohol intake, a healing rate of 99% was registered with OFI oil dose 2 and a healing rate of 80% was registered with OFI oil dose 1, while the gastric healing rates with ranitidine and sucralfate were quite similar to that of the untreated group (56%). Complete healing of ulcers was registered at the 4th day with OFI oil dose 2.

4. Discussion

Gastric ulcer is a disease that is spreading all over the world causing enhanced morbidity and mortality rates in humans. Its etiology is due to an imbalance between the protective and aggressive factors of the gastric mucosa. Allopathic medicines used in the treatment of this pathology have many side effects which can be very harmful. Therapeutics used in the treatment of gastric ulcer are based mainly on the use of proton pump inhibitors (PPIs) as well as drugs that reduce HCl production by acting on histamine H2-receptors and those that stimulate mucus synthesis or act as gastric dressings [6668]. Alternative medicine research focuses on the finding of new therapeutic tools that would be efficient to prevent the occurring of gastric injuries or ulcerations and to heal them if they already occurred with minimal or no side effects.

The current study highlighted the antiulcerative protective and healing efficiency of OFI oil extracted by cold pressing against acute peptic ulcer induced by absolute ethanol, in comparison to two allopathic reference drugs, sucralfate and ranitidine. Our data have shown that OFI oil has significantly reduced the severe mucosal damages (lesions, ulcers, bleeding, and necrosis) observed in several areas in the gastric wall of starved rats then orally treated with absolute ethanol (positive control). We noted a major protection with dose 2 (7 mL/kg/bw) compared to dose 1 (3.5 mL/kg/bw) as it may give sufficient amounts of active biocompounds to be efficient. Gastric parameters were better normalized (). The surface of ulcerated areas was much reduced by dose 2 oil pretreatment () vs. positive control and rats pretreated with reference drugs, thus strongly enhancing the percentage of ulcer inhibition. Mucus secretion has been stimulated, gastric juice pH was elevated, and its volume was reduced.

Pretreatment with the reference drugs had reduced the surface of the lesions and the necrosis areas in the gastric mucosa but the ulcerogenic effect of ethanol remained relatively strong. Ranitidine is a drug commonly administered to cure peptic ulcer and the gastroesophageal reflux disease (GERD) [66]. It acts as an antagonist of the H2-receptors reducing by this way the gastric mucosa acid secretion. Sucralfate is known as a gastroprotective agent that forms a layer on the gastric mucosa to act as a barrier against acidic secretions and irritating factors [67]. Our study had shown that the pretreatment with ranitidine slightly reduced the symptoms of peptic ulcer to a degree equivalent with that of sucralfate.

Our results are consistent with previous studies that have reported the ulcerative effect of orally applied ethanol on gastric mucosa [4144, 4648]. It induces disruptions in gastric mucosal integrity, epithelial cellular exfoliation, mucosal friability, inflammation, and local hemorrhage due to intensive microvascular changes. The noxious effects of ethanol were first attributed to the occurrence of an abnormal intense oxidative stress state in the gastric mucosa with increased reactive oxygen species (ROS) production. It has been proved that alcohol intake provoked an alleviation of the mitochondrial membrane potential, thus leading to a perturbation in the mitochondrial electron chain transfer and an overproduction of oxygen free radical O2- [69, 70]. Moreover, ROS production is associated to the formation of lipid peroxidation products such as MDA and the depletion of cellular enzymatic and nonenzymatic antioxidative defense systems such as SOD, CAT, and GPx [47]. It has been reported that ethanol-induced gastric injuries were correlated to an enhancement of MDA secretion levels in the gastric mucosa [46]. Our data have shown that OFI oil exhibited high scavenging activity against free radicals DPPH and ABTS, as % of radical inhibition, respectively, 88.41 and 87.42 Vit. C eq/g oil, allowing it to counteract in a preventive way ethanol oxidative effects on gastric mucosal cells. The antioxidative potential of OFI oil could be attributed to its richness in active biocompounds such as polyphenols (46.71 Gallic acid eq/g oil), flavonoids (3.1 mg Quercetin eq/100 g oil), carotenoids (10.52 mg/kg oil), chlorophylls (4.57 mg/kg oil), and Vitamin E tocopherols (863.21 mg/kg oil) with an average of 797.8 mg/kg oil for the fractions β- and γ-tocopherols. Indeed, several studies have attributed the antioxidant potentials of these compounds against the harmful effects of free radicals that induce pathophysiological states such as cardiovascular diseases, diabetes, and degenerative disorders like dementias and Parkinson’s disease [7176]. Pretreatment of gastric mucosa with OFI oil provided it with notable amounts of nonenzymatic antioxidants, thus stimulating the mechanisms of cellular defense against oxidative stress.

The linear and punctual lesions inflicted to gastric mucosa by absolute ethanol intake could be due to a direct damaging effect on mucosal cell membranes and to indirect effects by the stimulation of inflammatory pathways with an upregulation of gene expression of proinflammatory cytokines such as TNF-α, IL-1-β, IL-6, IL-16, TGF-β1, NF-κB (nuclear factor-kappa B), and iNOS (inducible nitric oxide synthase that generates the ulcerative NO via ROS production in gastric mucosal cells) and a downregulation of TGF-61 (Tumor growth factor-61) which actually regulates some signaling pathways including angiogenesis, cell proliferation, and extracellular matrix component differentiation [48]. TNF-α participates in gastric ulcer via promoting oxygen free radicals and enhancing apoptosis through the caspase cascade pathway and neutrophil migration into gastric mucosa facilitated by vessel congestion. Moreover, TNF-α is implicated in the activation of other intracellular inflammatory signaling pathways including INF-γ which upregulates its own production. Several studies have attributed the anti-inflammatory activities to plant sterols and especially to β-sitosterol as it displays inhibitory effects on proinflammatory agents such as IL-6 and TNF-α by monocytes [76, 77]. Furthermore, our phytochemical analysis of OFI oil has shown that it is rich in sterols especially in β-sitosterol (81.280 g/100 g of total sterols) and campesterol (11.043 g/100 g of total sterols). These compounds could further explain the antioxidant and the anti-inflammatory properties of this oil as a pretreatment in the protection of the gastric mucosa against ulcer. In fact, we could note a significant reduction of inflammatory leukocyte infiltration into mucosa and submucosa layers of the gastric wall.

Furthermore, ethanol evoked an overproduction of HCl by parietal cells, thus reducing gastric juice pH and enhancing gastric juice volume. However, OFI oil pretreatment especially with dose 2 significantly reduced gastric juice volume and acidity, thus minimizing acid aggression of the mucosa. HCl secretion takes place in the parietal cells of the oxyntic glands following stimulation by gastrin, produced by the endocrine G cells of the glands. Histamine secreted by ECL (enterochromaffin-like) cells from the fundic glands contributes to the stimulation of mucosal parietal cells [12].

The significant increase in pH of gastric juice and mucus weight () that we recorded after ulcer induction by absolute ethanol in rats pretreated with prickly pear oil (especially with dose 2) vs. negative control and sucralfate and ranitidine groups could suggest an inhibitory activity of this oil on H2-histaminic or on the other stimulatory pathways including gastrin and/or acetylcholine parietal cell receptors. In addition, OFI oil components could act on cellular pathways in Goblet cells whose main role is mucus secretion but also bicarbonate (HCO3-) which has an alkaline pH, in order to protect the gastric mucosa from the aggressive effects of HCl and pepsin. Furthermore, it has been reported that [78] prostaglandins (PGEs) and in particular prostaglandin E2 (PGE2) exhibit a gastroprotective effect by positively influencing mucosal integrity defense systems. They are able to enhance epithelial cell resistance to injury induced by cytotoxins and to stimulate mucus and bicarbonate synthesis and secretion. PGE synthesis depends mainly on the activity of two isoenzyme cyclooxygenases (COX), i.e., COX-1 and COX-2, that are involved in the synthesis pathway of arachidonic acid-derived eicosanoids (leukotrienes, thromboxanes, and prostaglandin). It has been shown that β- and γ-tocopherols are able to inhibit their activities and that of 5-lipoxygenase (5-LOX) that catalyzes leukotriene (LT) biosynthesis, thus limiting inflammatory symptoms induced by absolute ethanol on gastric mucosa [79]. Since OFI oil is very rich in β- and γ-tocopherol fraction Vitamin E, they may inhibit COX-1 and COX-2, leading indirectly to the enhancement of PGE2 and so to an increase in mucus production and mucosa protection. Moreover, the fatty acid analysis of OFI oil has shown that the major components are linoleic acid (C18 : 2 -6), oleic acid (C18 : 1 -9), and palmitic acid (C16 : 0) with, respectively, the rates of 61.63, 21.18, and 12.24 g/100 g of total free fatty acids. As described by previous studies, at sufficient levels, and in addition to their role in the construction and consolidation of cell membranes, these fatty acids are involved in anti-inflammatory cellular processes by inhibiting proinflammatory cytokines (TNF-alpha and IL-6) as well as COX-1 and COX-2 [80]. This is able to enhance mucus secretion and reduce HCl production by the cells of the gastric mucosa under the effect of a sufficient dose of OFI oil.

On one hand, our current study has demonstrated that OFI oil exhibited a strong healing effect of ethanol-induced gastric ulcer. The comparison between all experimental groups showed that gastric ulcer could heal naturally without treatment but in a slow mode. The healing process has been accelerated in ascending mode by ranitidine then sucralfate, OFI oil dose 1, and finally by OFI oil dose 2. The evolution of the ulcerated area during five days after inducing ulcer indicated a speeding-up of the healing process compared to the controls and to the reference drug-treated rats. In a previous work [53], we have demonstrated that OFI oil extracted under cold pressing has a high potential in the healing of full-thickness skin wounds in rats as well as in antimicrobial activities against bacteria, yeast, and fungi. We have noted an acceleration of the healing process compared to control and to a reference healing drug.

It should be remembered that the healing process is a very important phenomenon in restoring the integrity of the external (skin) and internal (mucous membranes) barriers of the human body. Any injury can be a gateway to germs and certain harmful or toxic substances.

The gastric ulcer healing process is an innate, genetically programmed injury repair of gastrointestinal mucosae. It includes overlapping phases: stopping blood loss if bleeding has occurred, inflammation, cell proliferation, reepithelialization and angiogenesis, granulation tissue formation, and extracellular matrix reconstitution and remodeling, as well as the reestablishment of gastric glands and other mucosal components [3]. As described above, our results revealed that intragastric force-feeding with ethanol caused severe necrotizing linear lesions with the loss of substance in gastric mucosa that affected even the submucosal layers, accompanied by vascular congestions, bleeding, and inflammatory infiltrations. Histologically, gastric ulcer has been described as two juxtaposed structures that complement each other to heal the wound: the base and the margin. It has been elucidated that the process of healing mucosal wounds is carried out through the action of a plethora of mediators and cytokines that are spilled and concentrated in the injured areas. The expression of their genes is induced in a well-synchronized spatial and time-delayed manner [81].

Cellular and molecular events occur in the ulcer margin (mainly in epithelial cells), while other events occur in its base (mesenchymal cells and extracellular matrix). For instance, EGF-R, c-fos, c-jun, egr-1, Sp-1, TFF-2/SP, PDGF, EGF, VEGF, HGF, bFGF, KGF, and TGF-β expression is triggered to activate, via several mechanisms such as autocrine and/or paracrine mechanisms, the epithelial cell migration of cells from the edges of the wound onto granulation tissue, to ensure reepithelialization. Moreover, cells lining gastric glands in the margin zone form tubes then undergo proliferation and differentiation to reconstruct damaged glands and mucosal crypts. At the base of the gastric ulcer, neoangiogenesis gets activated especially by VEGF, which stimulate endothelial cell migration, proliferation, differentiation, and capillary formation, thus restoring blood flow and providing nutrients and oxygen to the proliferating and differentiating epithelial and mesenchymal cells. Furthermore, it has been indicated that bone marrow-derived stem cells are able to migrate into the injured gastric mucosa and to differentiate in epithelial, endothelial, and glandular cells, contributing by this way to repopulating the human gastrointestinal tract [82].

OFI oil in sufficient amounts would on one hand have accelerated the ulcer healing rate by ensuring a protective lipid layer to the wound site against dehydration (like a dressing covering the mucosal crypts in a mimetic way such as sucralfate), thus promoting cytokine, growth, and transforming factor actions and on the other hand positively affected signaling pathways to restore the balance between aggressive and protective agents to regenerate mucosal components. This could be attributed to OFI oil antioxidants previously mentioned. The anti-inflammatory activity of phytosterols, especially β-sitosterol and PUFA, could corroborate the acceleration of ulcer healing by OFI oil. In an advanced stage, the reduction of acidity and gastric juice secretion under the effect of OFI oil would promote ulcer healing by filling then remodelling the extracellular matrix with structural proteins such as collagen types I, II, and III and elastin, proteoglycans, and hyaluronans. Reepithelialization, revascularization, and reconstruction of the glands and crypts covered by oil compounds, especially its unsaturated free fatty acids, would ensure the rapid restoration of the cytoarchitecture mucosa and the other layers of the gastric wall.

5. Conclusion

Our current findings suggest that Opuntia ficus indica seed oil extracted under cold pressing exhibited potent antioxidant, prophylactic, and therapeutic potentials against acute gastric ulcer induced by absolute ethanol. This is due to its richness in beneficial biocompounds which act in synergistic and complementary ways to ensure gastroprotection as well as gastric mucosal ulcer healing.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this article.

Acknowledgments

Special thanks are due to Dr. Abdelkhalek Ben Rajeb (Anatomopathological Explorations Laboratory, Ennasr, Tunis) for his assistance in histological gastric biopsy slide interpretation and to Dr. Kamel Ben Ammar (National Oil Office, Tunis) for facilitating of OFI oil analysis in their laboratory.

References

  1. D. J. Stewart and R. Ackroyd, “Peptic ulcers and their complications,” Surgery (Oxford), vol. 29, no. 11, pp. 568–574, 2011. View at: Publisher Site | Google Scholar
  2. P. Asanasak, “The case series of peritonitis due to perforated peptic ulcer: how does conservative management play role?” International Journal of Surgery Case Reports, vol. 58, pp. 74–76, 2019. View at: Publisher Site | Google Scholar
  3. A. F. Syam, M. Sadikin, S. I. Wanadi, and A. A. Rani, “Molecular mechanism on healing process of peptic ulcer,” Acta Medica Indonesiana, vol. 41, no. 2, pp. 95–98, 2009. View at: Google Scholar
  4. P. Malfertheiner, F. K. Chan, and K. E. McColl, “Peptic ulcer disease,” The Lancet, vol. 374, no. 9699, pp. 1449–1461, 2009. View at: Publisher Site | Google Scholar
  5. J. Y. Lau, J. Sung, C. Hill, C. Henderson, C. W. Howden, and D. C. Metz, “Systematic review of the epidemiology of complicated peptic ulcer Disease: Incidence, recurrence, risk factors and mortality,” Digestion, vol. 84, no. 2, pp. 102–113, 2011. View at: Publisher Site | Google Scholar
  6. R. T. Kavitt, A. M. Lipwska, A. Anyane-Yeboa, and I. M. Gralnek, “Diagnosis and Treatment of Peptic Ulcer Disease,” The American journal of medicine, vol. 132, no. 4, pp. 447–456, 2019. View at: Publisher Site | Google Scholar
  7. J. J. Y. Sung, E. J. Kuipers, and H. B. El-Serag, “Systematic review: the global incidence and prevalence of peptic ulcer disease,” Alimentary Pharmacology & Therapeutics, vol. 29, no. 9, pp. 938–946, 2009. View at: Publisher Site | Google Scholar
  8. F. A. Andoulo, D. N. Noah, M. Tagni-Sartre, E. C. Ndjitoyap, and K. N. Blackett, “Epidémiologie de l’infection à Helicobacter pylori à Yaoundé: de la particularité à l’énigme Africaine,” The Pan African Medical Journal, vol. 16, p. 115, 2013. View at: Publisher Site | Google Scholar
  9. L. M. Lawson-Ananissoh, O. Bouglouga, A. Bagny, R. E. H. Yakoubou, L. Kaaga, and D. Redah, “Profil épidémiologique des ulcères gastro-duodénaux au centre hospitalier et universitaire Campus de Lomé (Togo),” Journal African d’Hépato-Gastroentérologie, vol. 9, no. 3, pp. 99–103, 2015. View at: Publisher Site | Google Scholar
  10. X. Guo, B. H. Zhao, and M. X. Zhang, “Risk factors of Helicobacter pylori infection among adults in northern China,” Hepato-Gastroenterology, vol. 106, no. 106, pp. 306–310, 2011. View at: Google Scholar
  11. D. Majumdar and J. Bebb, “Helicobacter pylori infection and peptic ulcers,” Medicine, vol. 47, no. 5, pp. 292–300, 2019. View at: Publisher Site | Google Scholar
  12. L. Beaugeri and H. Sokol, Les Fondamentaux de la Pathologie Digestive, CDU-HE/Editions Elesevier-Masson, 2014.
  13. J. M. Havens, M. Castillo-Angeles, S. L. Nitzschke, and A. Salim, “Disparities in peptic ulcer disease: a nationwide study,” The American Journal of Surgery, vol. 216, no. 6, pp. 1127-1128, 2018. View at: Publisher Site | Google Scholar
  14. F. I. Tovey, D. Capanoglu, G. J. Langley et al., “Dietary phytosterols protective against peptic ulceration,” Gastroenterology research, vol. 4, no. 4, pp. 149–156, 2011. View at: Publisher Site | Google Scholar
  15. J. Y. Min and K. B. Min, “Cumulative exposure to nighttime environmental noise and the incidence of peptic ulcer,” Environmental International, vol. 121, Part 2, pp. 1172–1178, 2018. View at: Publisher Site | Google Scholar
  16. T. Serrano, E. Piazuelo, R. Benito, S. Santolaria, and A. Lanas, “Bleeding duodenal ulcer and association with polymorphism of endothelial constitutive nitric oxide synthase gene,” Digestive Diseases and Sciences, vol. 47, no. 5, pp. 996–1000, 2002. View at: Publisher Site | Google Scholar
  17. L. Laine, “Upper gastrointestinal bleeding due to a peptic ulcer,” The New England Journal of Medicine, vol. 374, no. 24, pp. 2367–2376, 2016. View at: Publisher Site | Google Scholar
  18. I. Jemni, H. L. Mohamed, F. Aissaoui et al., “Résultats de la prise en charge endoscopique de l’ulcère gastroduodénal hémorragique: une série de 125 patients,” Endoscopy, vol. 51, no. 3, article S39, 2019. View at: Publisher Site | Google Scholar
  19. D. Troland and A. Stanley, “Endotherapy of peptic ulcer bleeding,” Gastrointestinal Endoscopy Clinics of North America, vol. 28, no. 3, pp. 277–289, 2018. View at: Publisher Site | Google Scholar
  20. T. L. Srinivas, S. M. Lakshmi, S. N. Shama, G. K. Reddy, and K. R. Prasanna, “Medicinal plants as anti-ulcer agents,” Journal of Pharmacognosy and Phytochemistry, vol. 2, no. 4, pp. 91–97, 2013. View at: Google Scholar
  21. S. Chanda, Y. Baravalia, and M. Kaneria, “Protective effect of _Polyalthia longifolia_ var. pendula leaves on ethanol and ethanol/HCl induced ulcer in rats and its antimicrobial potency,” Asian Pacific Journal of Tropical Medicine, vol. 4, no. 9, pp. 673–679, 2011. View at: Publisher Site | Google Scholar
  22. C. Bourne, B. Charpiat, N. Charhon et al., “Effets indésirables émergents des inhibiteurs de la pompe à protons,” La Presse Médicale, vol. 42, no. 2, pp. 53–62, 2013. View at: Publisher Site | Google Scholar
  23. S. Asnaashari, S. Dastmalchi, and Y. Javadzadeh, “Gastroprotective effects of herbal medicines (roots),” International Journal of Food Properties, vol. 21, no. 1, pp. 902–920, 2018. View at: Publisher Site | Google Scholar
  24. F. Borelli and A. A. Izzo, “The plant kingdom as a source of anti-ulcer remedies,” Phytotherapy Research, vol. 14, no. 8, pp. 581–591, 2000. View at: Publisher Site | Google Scholar
  25. H. Falcao, I. R. Mariath, M. F. F. M. Diniz, L. M. Batista, and J. M. Barbosa-Filho, “Plants of the American continent with antiulcer activity,” Phytomedicine, vol. 15, no. 1-2, pp. 132–146, 2008. View at: Publisher Site | Google Scholar
  26. B. Mayer, C. H. Baggio, C. S. Freitas et al., “Gastroprotective constituents of Salvia officinalis L.,” Fitoterapia, vol. 80, no. 7, pp. 421–426, 2009. View at: Publisher Site | Google Scholar
  27. C. Fokunang, B. Ngameni, B. N. Nono, and E. Tembe-Fofunang, “Effet cytoprotecteur de l’extrait aqueux des racines de Dorstenia psilurus sur l’ulcère gastrique chez les rats mâles de la souche Wistar,” Health Sciences and Diseases, vol. 12, no. 4, 2013. View at: Google Scholar
  28. M. O. Ugwah, C. J. Ugwah-Oguejiofor, E. U. Etuk, S. O. Bello, and A. A. Aliero, “Evaluation of the antiulcer activity of the aqueous stem bark extract of Balanites aegyptiaca L Delile in Wistar rats,” Journal of ethnopharmacology, vol. 239, article 111931, 2019. View at: Publisher Site | Google Scholar
  29. E. M. Galati, M. T. Monforte, M. M. Tripodo, A. d’Aquino, and M. R. Mondello, “Antiulcer activity of Opuntia ficus indica (L.) Mill. (Cactaceae): ultrastructural study,” Journal of Ethnopharmacology, vol. 76, no. 1, pp. 1–9, 2001. View at: Publisher Site | Google Scholar
  30. E. M. Galati, S. Pergolizzi, N. Miceli, M. T. Monforte, and M. M. Tripodo, “Study on the increment of the production of gastric mucus in rats treated with Opuntia ficus indica (L.) Mill. cladodes,” Journal of Ethnopharmacology, vol. 83, no. 3, pp. 229–233, 2002. View at: Publisher Site | Google Scholar
  31. E. M. Galati, M. R. Mondello, D. Giuffrida et al., “Chemical characterization and biological effects of Sicilian Opuntia ficus indica (L.) Mill. fruit juice: antioxidant and antiulcerogenic activity,” Journal of Agricultural and Food Chemistry, vol. 51, no. 17, pp. 4903–4908, 2003. View at: Publisher Site | Google Scholar
  32. E. M. Galati, M. T. Monforte, M. R. Mondello, M. F. Taviano, M. Galluzzo, and M. M. Tripodo, “Opuntia ficus indica (L.) Mill. mucilages show cytoprotective effect on gastric mucosa in rat,” Phytotherapy Research, vol. 21, no. 4, pp. 344–346, 2007. View at: Publisher Site | Google Scholar
  33. H. Alimi, N. Hfaiedh, Z. Bouoni et al., “Antioxidant and antiulcerogenic activities of _Opuntia ficus indica f. inermis_ root extract in rats,” Phytomedicine, vol. 17, no. 14, pp. 1120–1126, 2010. View at: Publisher Site | Google Scholar
  34. J. C. Lee, H. R. Kim, J. Kim, and Y. S. Jang, “Antioxidant property of an ethanol extract of the stem of Opuntia ficus-indica var. saboten,” Journal of Agricultural and Food Chemistry, vol. 50, no. 22, pp. 6490–6496, 2002. View at: Publisher Site | Google Scholar
  35. H. Shay, “A simple method for the uniform production of gastric ulceration in the rat,” Gastroenterology, vol. 5, pp. 43–45, 1945. View at: Google Scholar
  36. G. Prino, S. Palialunga, G. Nardi, and A. Lietti, “Inhibition of experimentally-induced gastric ulcers in the rat by a new sulfated glycopeptide,” European Journal of Pharmacology, vol. 15, no. 1, pp. 119–126, 1971. View at: Publisher Site | Google Scholar
  37. X. M. Liu, M. N. M. Zakaria, M. W. Islam et al., “Anti-inflammatory and anti-ulcer activity of Calligonum comosum in rats,” Fitoterapia, vol. 72, no. 5, pp. 487–491, 2001. View at: Publisher Site | Google Scholar
  38. A. S. AlRashdi, S. M. Salama, S. S. Alkiyumi et al., “Mechanisms of Gastroprotective Effects of Ethanolic Leaf Extract of Jasminum sambac against HCl/Ethanol-Induced Gastric Mucosal Injury in Rats,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 786426, 15 pages, 2012. View at: Publisher Site | Google Scholar
  39. X. Zhao, J. Li, Y. Meng, M. Cao, and J. Wang, “Treatment Effects of Jinlingzi Powder and Its Extractive Components on Gastric Ulcer Induced by Acetic Acid in Rats,” Evidence-based Complementary and Alternative Medicine, vol. 2019, Article ID 7365841, 12 pages, 2019. View at: Publisher Site | Google Scholar
  40. N. Kangwan, K. Pintha, S. Lekawanvijit, and M. Suttajit, “Rosmarinic Acid Enriched Fraction from Perilla frutescens Leaves Strongly Protects Indomethacin-Induced Gastric Ulcer in Rats,” Biomed Research International, vol. 2019, Article ID 9514703, 13 pages, 2019. View at: Publisher Site | Google Scholar
  41. H. Alimi, N. Hfaiedh, Z. Bououni, M. Sakly, and K. Ben Rhouma, “Evaluation of antioxidant and antiulcerogenic activities of Opuntia ficus indica f. inermis flowers extract in rats,” Environmental Toxicology and Pharmacology, vol. 32, no. 3, pp. 406–416, 2011. View at: Publisher Site | Google Scholar
  42. R. Al Batran, F. Al-Bayaty, M. M. J. Al-Obaidi et al., “In vivo antioxidant and antiulcer activity of Parkia speciosa ethanolic leaf extract against ethanol-induced gastric ulcer in rats,” PLoS One, vol. 8, no. 5, article e64751, 2013. View at: Publisher Site | Google Scholar
  43. H. M. A. Sidahmed, A. H. S. Azizan, S. Mohan et al., “Gastroprotective effect of desmosdumotin C isolated from Mitrella kentii against ethanol-induced gastric mucosal hemorrhage in rats: possible involvement of glutathione, heat-shock protein-70, sulfhydryl compounds, nitric oxide, and anti-Helicobacter pylori activity,” BMC Complementary and Alternative Medicine, vol. 13, no. 1, article 183, 2013. View at: Publisher Site | Google Scholar
  44. C. Mezui, F. Longo, P. Tan, C. Nkenfou, N. Fokou, and H. Salou, “Effects of the stem barks aqueous extract of Anthocleista scweinfurthii Gilg (Loganiaceae) on acute and chronic gastric ulcers in rats models,” Journal of Medicinal Plants Research, vol. 9, no. 23, pp. 674–680, 2015. View at: Google Scholar
  45. I. M. Boutemine, M. Amri, Z. C. Amir et al., “Gastro-protective, therapeutic and anti-inflammatory activities of Pistacia lentiscus L. fatty oil against ethanol-induced gastric ulcers in rats,” Journal of Ethnopharmacology, vol. 224, pp. 273–282, 2018. View at: Publisher Site | Google Scholar
  46. D. Ortaç, M. Cemek, T. Karaca et al., “In vivo anti-ulcerogenic effect of okra (Abelmoscus esculentus) on ethanol-induced acute gastric mucosal lesions,” Pharmaceutical Biology, vol. 56, no. 1, pp. 165–175, 2018. View at: Publisher Site | Google Scholar
  47. O. Guzmán-Gómez, R. García-Rodríguez, L. Quevedo-Corona et al., “Amelioration of ethanol-induced gastric ulcers in rats pretreated with phycobiliproteins of Arthrospira (Spirulina) Maxima,” Nutrients, vol. 10, no. 6, p. 763, 2018. View at: Publisher Site | Google Scholar
  48. M. A. Lebda, A. H. El-Far, A. E. Noreldin, Y. H. Elewa, S. K. Al Jaouni, and S. A. Mousa, “Protective Effects of Miswak (Salvadora persica) against Experimentally Induced Gastric Ulcers in Rats,” Oxidative Medicine and Cellular Longevity, vol. 2018, Article ID 6703296, 14 pages, 2018. View at: Publisher Site | Google Scholar
  49. S. Bardaa, N. B. Halima, F. Aloui et al., “Oil from pumpkin (Cucurbita pepo L.) seeds: evaluation of its functional properties on wound healing in rats,” Lipids in health and disease, vol. 15, no. 1, article 73, 2016. View at: Publisher Site | Google Scholar
  50. S. Bardaa, D. Moalla, S. Ben Khedir, T. Rebai, and Z. Sahnoun, “The evaluation of the healing proprieties of pumpkin and linseed oils on deep second-degree burns in rats,” Pharmaceutical Biology, vol. 54, no. 4, pp. 581–587, 2016. View at: Publisher Site | Google Scholar
  51. M. R. Farahpour and S. Fathollahpour, “Topical co-administration of flaxseed and pistachio ointment promoted wound healing; evidence for histopathological features,” Comparative Clinical Pathology, vol. 24, no. 6, pp. 1455–1461, 2015. View at: Publisher Site | Google Scholar
  52. F. J. Menvielle-Bourg and F. Joanny, “L’extrait huileux au CO2 supercritique de baies et de graines d’argousier (Hippophae rhamnoides L.) et ses effets sur la peau et les muqueuses,” Phytothérapie, vol. 7, no. 1, pp. 3–7, 2009. View at: Publisher Site | Google Scholar
  53. I. Khémiri, B. Essghaier Hédi, N. Sadfi Zouaoui, N. Ben Gdara, and L. Bitri, “The Antimicrobial and Wound Healing Potential of Opuntia ficus indica L. inermis Extracted Oil from Tunisia,” Evidence-based Complementary and Alternative Medicine, vol. 2019, Article ID 9148782, 10 pages, 2019. View at: Publisher Site | Google Scholar
  54. L. D. Metcalfe, A. A. Schmitz, and J. R. Pelka, “Rapid preparation of fatty acid esters from lipids for gas chromatographic analysis,” Analytical Chemistry, vol. 38, no. 3, pp. 514-515, 1966. View at: Publisher Site | Google Scholar
  55. D. Lechevallier, “Les lipids des Lemnacees—analyse des acides gras des lipids des fronds de Spirodela polyrrhiza,” Comptes Rendus Hebdomadaires des séances de l’Académie des Sciences Série D, vol. 263, no. 23, article 1849, 1966. View at: Google Scholar
  56. S. H. Fatemi and E. G. Hammond, “Analysis of oleate, linoleate and linolenate hydroperoxides in oxidized ester mixtures,” Lipids, vol. 15, no. 5, pp. 379–385, 1980. View at: Publisher Site | Google Scholar
  57. W. Moreda, M. D. C. Pérez-Camino, and A. Cert, “Improved method for the determination of triacylglycerols in olive oils by high performance liquid chromatography,” Grasas y Aceites, vol. 54, no. 2, pp. 175–179, 2003. View at: Publisher Site | Google Scholar
  58. M. T. Morales and M. Léon-Camacho, “Gas and liquid chromatography: methodology applied to olive oil,” in Handbook of Olive Oil, J. Harwood and R. Aparicio, Eds., pp. 159–207, Springer, Boston, MA, USA, 2000. View at: Publisher Site | Google Scholar
  59. C. Paquot and A. Hautfenne, “Standard methods for the analysis of oils, fats and derivatives,” Pure and Applied Chemistry, vol. 51, pp. 2503–2526, 1979. View at: Google Scholar
  60. M. I. Minguez-Mosquera, B. Gandul-Rojas, A. Montano-Asquerino, and J. Garrido-Fernandez, “Dertermination of chlorophylls and carotenoids by high-performance liquid chromatography during olive lactic fermentation,” Journal of Chromatography A, vol. 585, no. 2, pp. 259–266, 1991. View at: Publisher Site | Google Scholar
  61. C. El Kar, A. Ferchichi, F. Attia, and J. Bouajila, “Pomegranate (Punica granatum) Juices: Chemical Composition, Micronutrient Cations, and Antioxidant Capacity,” Journal of food Science, vol. 76, no. 6, pp. C795–C800, 2011. View at: Publisher Site | Google Scholar
  62. T. Bahorun, B. Gressier, F. Trotin et al., “Oxygen species scavenging activity of phenolic extracts from hawthorn fresh plant organs and pharmaceutical preparations,” Azneimittel-Forschung, vol. 46, no. 11, pp. 1086–1089, 1996. View at: Google Scholar
  63. H. Bendaoud, M. Romdhane, J. P. Souchard, S. Cazaux, and J. Bouajila, “Chemical composition and anticancer and antioxidant activities of Schinus molle L. and Schinus terebinthifolius Raddi berries essential oils,” Journal of Food Science, vol. 75, no. 6, pp. C466–C472, 2010. View at: Publisher Site | Google Scholar
  64. P. V. Tan, N. G. Nditafon, M. P. Yewah, T. Dimo, and F. J. Ayafor, “Eremomastax speciosa : effects of leaf aqueous extract on ulcer formation and gastric secretion in rats,” Journal of Ethnopharmacology, vol. 54, no. 2-3, pp. 139–142, 1996. View at: Publisher Site | Google Scholar
  65. V. C. Njar, J. K. Adesanwo, and Y. Raji, “Methyl angolensate: the antiulcer agent of the stem bark ofEntandrophragma angolense,” Planta Medica, vol. 61, no. 01, pp. 91-92, 1995. View at: Publisher Site | Google Scholar
  66. N. D. Yeomans, Z. Tulassay, L. Juasz et al., “A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group,” The New England Journal of Medicine, vol. 338, no. 11, pp. 719–726, 1998. View at: Publisher Site | Google Scholar
  67. K. Eamlamnam, S. Patumraj, N. Visedopas, and D. Thong-Ngam, “Effects of Aloe vera and sucralfate on gastric microcirculatory changes, cytokine levels and gastric ulcer healing in rats,” World Journal of Gastroenterology, vol. 12, no. 13, article 2034, 2006. View at: Publisher Site | Google Scholar
  68. O. Reinberg, “Proton pump inhibitors (PPI): may be not as harmless as believed,” Revue Médicale Suisse, vol. 11, no. 485, pp. 1665–1671, 2015. View at: Google Scholar
  69. Q. Sun, W. Zhong, W. Zhang, and Z. Zhou, “Defect of mitochondrial respiratory chain is a mechanism of ROS overproduction in a rat model of alcoholic liver disease: role of zinc deficiency,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 310, no. 3, pp. G205–G214, 2015. View at: Publisher Site | Google Scholar
  70. M. Tamura, H. Matsui, T. Kaneko, and I. Hyodo, “Alcohol is an oxidative stressor for gastric epithelial cells: detection of superoxide in living cells,” Journal of Clinical Biochemistry and Nutrition, vol. 53, no. 2, pp. 75–80, 2013. View at: Publisher Site | Google Scholar
  71. P. Jenner, “Oxidative stress in Parkinson's disease,” Annals of Neurology, vol. 53, no. S3, pp. S26–S38, 2003. View at: Publisher Site | Google Scholar
  72. R. Blomhoff, “Dietary antioxidants and cardiovascular disease,” Current Opinion in Lipidology, vol. 16, no. 1, pp. 47–54, 2005. View at: Google Scholar
  73. E. R. Sindhu and R. Kuttan, “Carotenoid lutein protects rats from gastric ulcer induced by ethanol,” Journal of Basic and Clinical Physiology and Pharmacology, vol. 23, no. 1, pp. 33–37, 2012. View at: Publisher Site | Google Scholar
  74. D. E. Stevenson, “Polyphenols as adaptogens—the real mechanism of the antioxidant effect,” in Bioactive Compounds in Phytomedicine, pp. 143–162, InTech, Rijeka, 2012. View at: Google Scholar
  75. C. S. Atwood, X. Huang, R. D. Moir, R. E. Tanzi, and A. I. Bush, “Role of free radicals and metal ions in the pathogenesis of Alzheimer’s disease,” in Metal Ions in Biological Systems, A. Sigel, Ed., vol. 36 of Interrelations Between Free Radicals and Metal Ions in Life Processes, pp. 309–364, Routledge, 2018. View at: Publisher Site | Google Scholar
  76. P. J. Bouic, “The role of phytosterols and phytosterolins in immune modulation: a review of the past 10 years,” Current Opinion in Clinical Nutrition & Metabolic Care, vol. 4, no. 6, pp. 471–475, 2001. View at: Publisher Site | Google Scholar
  77. R. Aldini, M. Micucci, M. Cevenini et al., “Anti-inflammatory effect of phytosterols in experimental murine colitis model: prevention, induction, remission study,” PLos One, vol. 9, no. 9, article e108112, 2014. View at: Publisher Site | Google Scholar
  78. M. E. Sanchez-Mendoza, B. Reyes-Trejo, P. Sanchez-Gomez et al., “Bioassay-guided isolation of an anti-ulcer chromene from Eupatorium aschenbornianum: Role of nitric oxide, prostaglandins and sulfydryls,” Fitoterapia, vol. 81, no. 1, pp. 66–71, 2010. View at: Publisher Site | Google Scholar
  79. B. Yang and H. Kallio, “Composition and physiological effects of sea buckthorn (Hippophaë) lipids,” Trends in Food Science & Technology, vol. 13, no. 5, pp. 160–167, 2002. View at: Publisher Site | Google Scholar
  80. T. Rinbom, U. Huss, Å. Stenholm et al., “Cox-2 inhibitory effects of naturally occurring and modified fatty acids,” Journal of Natural Products, vol. 64, no. 6, pp. 745–749, 2001. View at: Publisher Site | Google Scholar
  81. A. S. Tarnawski, “Cellular and molecular mechanisms of gastrointestinal ulcer healing,” Digestive Diseases and Sciences, vol. 50, no. S1, pp. S24–S33, 2005. View at: Publisher Site | Google Scholar
  82. R. Okamoto, T. Yajima, M. Yamazaki et al., “Damaged epithelia regenerated by bone marrow–derived cells in the human gastrointestinal tract,” Nature Medicine, vol. 8, no. 9, article 1011, 2002. View at: Google Scholar

Copyright © 2019 Ikram Khémiri and Lotfi Bitri. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views857
Downloads336
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.